Clinical Trials Directory

Trials / Approved For Marketing

Approved For MarketingNCT01983722

Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

Status
Approved For Marketing
Phase
—
Study type
Expanded Access
Enrollment
—
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
All
Age
6 Months
Healthy volunteers
—

Summary

Expanded access to Stiripentol for patients with Dravet Syndrome.

Detailed description

This is a treatment plan, and therefore patients will be monitored according to clinical standard of care.

Conditions

Interventions

TypeNameDescription
DRUGStiripentol

Timeline

First posted
2013-11-14
Last updated
2026-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01983722. Inclusion in this directory is not an endorsement.

Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome (NCT01983722) · Clinical Trials Directory